Towards Healthcare

Infertility Treatment Companies | Innovation and Product Evolution | Strategic Resource Allocation | Corporate Restructuring | Financial Performance Evaluation

Date: November 2024

Infertility Treatment Market Size and Manufacturers

The global infertility treatment market size is calculated at USD 1.70 billion in 2024 and is expected to be worth USD 3.65 billion by 2034, expanding at a CAGR of 7.9% from 2024 to 2034. The desire for parenthood has driven a booming market in infertility treatments.

Infertility Treatment Top Companies:

  • Merck & Co.
  • Bayer AG
  • Ferring Pharmaceuticals
  • Thermo Fisher Scientific Inc.
  • CooperSurgical Fertility Company
  • Olympus
  • GE Healthcare
  • Medtronic
  • Cook Medical
  • IVFtech ApS

Infertility Treatment Market Companies

Competitive Landscape

The competitive landscape of the infertility treatment market is characterized by a diverse range of players, including pharmaceutical companies, medical device manufacturers, fertility clinics, and healthcare providers. These entities compete based on technological innovation, treatment success rates, pricing, geographic reach, and patient satisfaction. Fertility clinics and ART centers offer a range of infertility treatments and services, including IVF, IUI, and fertility preservation. These facilities compete based on success rates, treatment options, patient experience, and pricing. Diagnostic laboratories offer a range of fertility testing services, including semen analysis, hormone testing, and genetic screening, to assess the underlying causes of infertility and guide treatment decisions.

Latest Announcements by Industry Leaders

Todd Watts, Co-Founder and CEO of PatientFi commented on its collaboration with EngagedMD that the partnership was formed to make fertility care more accessible and educate patients about their financing options. He also added that the average treatment cost of fertility treatment is around $12,000 to $15,000 per cycle but their company can act as a catalyst to remove financial barriers for both the clinics and the patients.

Recent Developments in the Infertility Treatment Market

  • In November 2024, India IVF secured a funding of $1.25 million in pre-series A funding from Tomorrow Capital to bridge critical gaps in fertility care access, especially in North India.
  • In August 2024, Jindal IVF announced a strategic partnership with Mandav Hospital to enhance patient accessibility and convenience by offering comprehensive fertility services locally.
  • In April 2024, Ovom Care, a Berlin-based company, announced the successful closure of its seed funding round of €4.8 million from Alpha Intelligence, Ananda Impact Ventures, and Merantix to enable AI-enabled and data-driven medical care into the modern fertility care infrastructure.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com